Online Reporter
Sikhumbuzo Moyo
The Medicines Control Authority of Zimbabwe (MCAZ) has issued new guidelines for implementing traceability of medical products in Zimbabwe.
These guidelines apply to all medical products manufactured, imported, exported, advertised, sold, distributed, or used within the country, ensuring they remain traceable throughout the supply chain.
In Circular 22 of 2025, signed by MCAZ Director-General Mr Richard Rukwata, the notice is addressed to manufacturers, wholesalers, license holders—including pharmacies, industrial clinics, and dispensing medical or veterinary practitioners.
“MCAZ wishes to advise all stakeholders that the Guidelines for Implementing Traceability for Medical Products in Zimbabwe (MCAZ/LED/GL-22) have officially come into effect as of 18th July 2025. These guidelines apply to all medical products that are manufactured, imported, exported, advertised, sold, distributed, or used in Zimbabwe and are aimed at ensuring that such products are traceable throughout the entire supply chain,” reads the circular.
The framework is expected to reduce the circulation of falsified medicines, strengthen recall mechanisms, and promote public confidence in the quality of medical products available on the market.
“The guidelines are issued pursuant to Section 37 of the Medicines and Allied Substances Control (General) Regulations, 1991 (SI 150 of 1991), which empowers the Authority to prescribe labelling and traceability requirements for medical products,” the Authority stated.
